Job Description

Introduction and role purpose

GSK\xe2\x80\x99s General Medicines therapeutic area (TA) is vital to GSK, with a portfolio of trusted brands that will impact the lives of 700 million patients in the next decade. General Medicines delivers ~\xc2\xa39bn in sales for GSK and
90% of all of GSK pharmaceuticals volumes across ~150 brands and 10,000 SKUs to ~110 countries.

It is our ambition to transform General Medicines from delivering \xe2\x80\x9cbroadly stable\xe2\x80\x9d sales into being a growth engine for GSK. To achieve this, we have defined and are implementing disease area strategies in partnership with R&D, medical, commercial and corporate development. These strategies have and continue to shape our portfolio through targeted business development (BD) acquisitions and in-licensing deals.

In order to support the robust and disciplined Medical evaluation, pursuit and integration of BD opportunities, we require a dedicated Early Global Medical Affairs Lead (GMAL) to work closely with the Product & Disease Area Strategy team, Corporate Business Development team and relevant Medical SMEs.

This is a high-visibility strategic role with the potential to drive improved patient outcomes and \xc2\xa3bn impact through Business Development for General Medicines. He/she will require novel and agile ways of working, connections to country-level Medical Affairs and external expert input, and an ability to combine scientific understanding with a practical grasp of patient unmet need, physician perspectives, treatment landscape and payer priorities.

Key elements/responsibilities of role

• Develop and execute the Medical evaluation of BD and new pipeline assets based on the General Medicines TA needs, licensing deals and divestments, in collaboration with the relevant Medical SMEs (incl. GMALs, key LOC MALs etc.)
• In partnership with other leaders, drive the evolution of robust Medical BD foundation, providing the strategic medical perspective
• Build the Medical assessment framework to drive disciplined and systematic evaluation of opportunities
• Build deep understanding (incl. through external insights generation/advice seeking) of the:

• Pathophysiology of target diseases, the science behind target mechanisms of action and their potential benefits in clinical practice
• Target patient population, patient pathway and current/future treatment landscape (incl. competitor assets in development)
• Facilitate the input into the Integrated Asset Plan (IAP) work packages necessary to define the strategy and forecast the valuation of business development targets, including:

• Situational analysis and disease overview
• Target Medicine profile
• Forecast and valuation
• Marketing plan based on a differentiated product profile
• Pricing and market access plan
• Work in close partnership with commercial portfolio to effectively work through the business development and due diligence processes, ensuring key milestones and work packages are delivered on time and to an exceptional standard
• Support for driving alignment around the investment thesis, business case and value proposition for BD opportunities with key GCLT stakeholders (e.g., Regional Heads, GPS Heads, Chief Commercial Officer) to promote accelerated progress through Due Diligence and the deal process
• Support alignment across relevant strategic plans (e.g., CDP; TMP, CMC; biomarker strategy; key claims; investment thesis & business case) for BD targets
• Support the investment thesis and business case generation, review and approval process via the Forecast Review Committee (FRC)
• Lead integration planning and integration for BD acquisitions incl. day 1 readiness and resource demand planning
• Provide global medical affairs leadership for acquired assets until handover to dedicated Medical Leads incl. (but not limited to):

• Strategic medical insights into R&D and commercialization strategies: profiling patient pathways; mapping the treatment landscape and how it may evolve in the lifecycle of the asset; identifying gaps and opportunities based on emerging data, competitor activity and understanding of diverse healthcare systems
• Strategic alignment with clinical development and central and regional partner functions, to develop and optimize the medicine profile and evidence generation plans in support of the scientific value proposition of assigned assets and aligns resource needs
• Global scientific engagement strategy for the asset, including at scientific congresses, advisory boards or other events where appropriate. Drives excellence in scientific engagement with key stakeholders (HCPs, Patients, Payers and Regulators) to gather medical insights and build a deep understanding of customer needs to inform and shape the portfolio\xe2\x80\x99s development program
• Contributing expertise in scientific issues related to clinical development, study design, data interpretation and study conclusions

Basic qualifications and experience

• Medical Doctor with broad industry experience
• Experience as a medical affairs leader at country and global level
• Experience of Clinical Development in Respiratory or Infectious Diseases
• Experience of working & engaging successfully with external experts
• Experience of working within a matrix environment
• Ability to clearly identify priorities and manage multiple tasks
• Ability to strategically plan & work across boundaries and geographies effectively
• Experience of assimilating information rapidly and identifying critical questions that will drive decision-making and planning
• Ability to manage ambiguity, evaluate benefit and risk and take appropriate accountability for decision making
• Experience in considering scientific data and practical healthcare delivery needs from diverse health systems to optimise medical implementation of innovation
• Experience of collaborative team working with a wide range of stakeholders internally and externally
• Experience of working with health outcomes, go-to-market models, commercial positioning, market access and reimbursement requirements

Preferred experience

• MBA
• Consulting or Venture Capital experience

Why Us?

GSK is a global biopharma company with a special purpose \xe2\x80\x93 to unite science, technology and talent to get ahead of disease together \xe2\x80\x93 so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns \xe2\x80\x93 as an organization where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it\xe2\x80\x99s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We\xe2\x80\x99re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.

As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to neurodiversity, race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class*(*US only).

We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on or 0808 234 4391. Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels

As you apply, we will ask you to share some personal information which is entirely voluntary. We want to have an opportunity to consider a diverse pool of qualified candidates and this information will assist us in meeting that objective and in understanding how well we are doing against our inclusion and diversity ambitions. We would really appreciate it if you could take a few moments to complete it. Rest assured, Hiring Managers do not have access to this information and we will treat your information confidentially.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK\'s commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK\xe2\x80\x99s compliance to all federal and state US Transparency requirements. For more information, please visit GSK\xe2\x80\x99s Transparency Reporting site.

We\xe2\x80\x99re moving towards a more sustainable future with our new headquarters. With better public transport links and proximity to world-class science and technology institutions, we\xe2\x80\x99re excited for our move to the vicinity of Earnshaw Street, London WC1A (\xe2\x80\x9cthe New HQ\xe2\x80\x9d) by end H1 2024.

GlaxoSmithKline